Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease
E Makri, A Goulas, SA Polyzos - Archives of medical research, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis
M Kugelmas, M Noureddin, N Gunn, K Brown… - Liver …, 2023 - Wiley Online Library
There is ongoing recognition of the burden of non‐alcoholic fatty liver disease (NAFLD) and
non‐alcoholic steatohepatitis (NASH), with fibrosis being the most important histological …
non‐alcoholic steatohepatitis (NASH), with fibrosis being the most important histological …
Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index …
Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …
The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Y Fouad, G Esmat, R Elwakil, S Zakaria… - Saudi Journal of …, 2022 - journals.lww.com
The landscape of chronic liver disease in Egypt has drastically changed over the past few
decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to …
decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to …
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
YJ Zhou, F Gao, WY Liu, GLH Wong… - Alimentary …, 2021 - Wiley Online Library
Summary Background Recently, Papatheodoridi et al proposed to refine the Baveno VI
elastography dual‐cutoffs and introduce an algorithm for the detection of compensated …
elastography dual‐cutoffs and introduce an algorithm for the detection of compensated …
[HTML][HTML] The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
Materials and Methods: A total of 909 consecutive patients who presented with dyspepsia at
8 tertiary care centers in Turkey between March 2019 and December 2019 were included …
8 tertiary care centers in Turkey between March 2019 and December 2019 were included …
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic
liver disease worldwide–with an estimated global prevalence of 37%. Different from …
liver disease worldwide–with an estimated global prevalence of 37%. Different from …
Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
KM Kim, JH Roh, S Lee, JH Yoon - Scientific Reports, 2021 - nature.com
Recently, there has been an increasing interest in the therapeutic efficacy of RAS inhibitors
(RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce …
(RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce …
Prevalence of non-alcoholic fatty liver disease in the Russian Ural Eye and Medical Study and the Ural Very Old Study
MM Bikbov, TR Gilmanshin, RM Zainullin… - Scientific Reports, 2022 - nature.com
Abstract Information about prevalence and associated factors of non-alcoholic fatty liver
disease (NAFLD) has been scarce for the Russian, Eastern European and Central Asian …
disease (NAFLD) has been scarce for the Russian, Eastern European and Central Asian …